Figure
3. NCCLS Breakpoints for Selective Antifungal Agents Active Against
Candida Species
+DD = dose dependent
*Specific
breakpoints not defined but cumulative data suggest isolates with this MIC are
probably resistant
I: defined as Intermediate Susceptibility, not by dose dependent
susceptibility NCCLS breakpoints for caspofungin and voriconazole have not been
established
[Close Window]
From: HIV Web Study <www.hivwebstudy.org>
© 2006-08 University of Washington